SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported first-quarter net income of $16.6 million, after reporting a loss in the same period a year earlier.On a per-share basis, the San Diego-based company said it had net income of 10 cents.The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.The drugmaker posted revenue of $205.8 million in the period, missing Street forecasts. Eight analysts surveyed by Zacks expected $206.9 million.
Acadia, page-470
-
- There are more pages in this discussion • 481 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.31 |
Change
1.040(8.48%) |
Mkt cap ! $1.699B | |||
| Open | High | Low | Value | Volume |
| $12.95 | $13.36 | $12.79 | $6.524M | 500.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 736 | $13.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.31 | 172 | 7 |
View Market Depth
| Last trade - 14.24pm 06/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |